Vitaly Omelyanovskiy - Center for Healthcare Quality Assessment and Control, FSBI ''Financial Research Institute''

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 47 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A diagnostic and economic evaluation of the complex artificial intelligence algorithm aimed to detect 10 pathologies on the chest CT images

Valeria Yu. Chernina,Mikhail G. Belyaev, Anton Yu. Silin,Ivan O. Avetisov,Ilya A. Pyatnitskiy,Ekaterina A. Petrash,Maria V. Basova,Valentin E. Sinitsyn,Vitaly V. Omelyanovskiy,Victor A. Gombolevskiy

medRxiv (Cold Spring Harbor Laboratory) (2023)

引用0浏览0引用

Key business processes in healthcare and their readiness for digital transformation

L.D. Pestrenin, Yu.V. Seryapina,D.V. Fedyaev,V.V. Omelyanovskiy

Medical Technologies. Assessment and Choice (2022)

引用2浏览0引用

Economic evaluation of providing patients with test strips for blood glucose level monitoring with a frequency indicated in clinical guidelines in the Russian Federation

O.A. Sukhorukikh,T.O. Bessonova, E.G. Fedina,V.V. Omelyanovskiy

Medical Technologies. Assessment and Choice (2022)

引用0浏览0引用

Main changes in the model of diagnosis-related groups in 2022

V.V. Omelyanovskiy,M.V. Avxentyeva,I.A. Zheleznyakova,A.V. Zuev, Yu.S. Zueva,M.L. Lazareva, O.S. Plakhotnik, Yu.A. Voskresenskaya, T.S. Avyaeva

Medical Technologies. Assessment and Choiceno. 2 (2022): 8-8

引用0浏览0引用

Improving the efficiency of the medicine provision system for patients with malignant neoplasms

Yu. A. Agafonova,D. V. Fedyaev,A. V. Snegovoy,V. V. Omelyanovskiy

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology（2022）

引用0浏览0引用

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation

T. O. Bessonova,F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova,V. V. Omelyanovskiy,S. N. Krivolapov, N. M. Neminushchiy,A. A. Kalemberg

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiologyno. 1 (2022): 5-22

引用0浏览0引用

Economic evaluation of therapeutic education (in diabetes school) for patients with type 1 and type 2 diabetes mellitus

V.K. Fedyaeva,V.V. Omelyanovskiy,O.A. Sukhorukikh, A.O. Ryzhov, A.A. Mochalova

Medical Technologies. Assessment and Choice (2022)

引用1浏览0引用

Main changes in the model of diagnosis-related groups in 2021

V.V. Omelyanovskiy,M.V. Avxentyeva,I.A. Zheleznyakova,M.L. Lazareva,D.V. Fedyaev,A.V. Zuev

Medical Technologies. Assessment and Choice (2021)

引用4浏览0引用

Concept of value-based healthcare

N. Z. Musina,V. V. Omelyanovskiy, R. V. Gostischev,O. A. Sukhorukikh,V. K. Fedyaeva,N. N. Sisigina, D. G. Shchurov

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology（2021）

引用5浏览0引用

Valuation of the EQ-5D-3L in Russia

Vitaly Omelyanovskiy, Nuriya Musina,Svetlana Ratushnyak,Tatiana Bezdenezhnykh, Vlada Fediaeva,Bram Roudijk,Fredrick Dermawan Purba

QUALITY OF LIFE RESEARCH（2021）

引用12浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn